Mental Distress
0
Pipeline Programs
1
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Young BioPharmaMA - Lowell
2 programsCognitive Behavioral Therapy for InsomniaN/A1 trial
Narrative TherapyN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2025
2026
2027
Young BioPharmaNarrative Therapy
Young BioPharmaCognitive Behavioral Therapy for Insomnia
Clinical Trials (2)
Total enrollment: 1,540 patients across 2 trials
Narrative Therapy Among Young People With Moderate Level of Mental Distress in Hong Kong
Start: Dec 2025Est. completion: Aug 2027770 patients
N/ARecruiting
Cognitive Behavioural Therapy for Insomnia Among Young People With Moderate Level of Mental Distress in Hong Kong
Start: Nov 2025Est. completion: Aug 2027770 patients
N/ANot Yet Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 1,540 patients
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.